Biologic Therapy Trials for Kidney Cancer, Melanoma and Other Solid Tumors
Biologic therapies are drugs that change the way cells work. In recent years they have shown increasing promise in treating kidney cancer, melanoma and other solid tumors.
There are two main types of biologic therapy:
- Targeted therapies target specific gene mutations to destroy cancer cells
- Immunotherapy drugs spur the body's immune system to attack the cancer
The BIDMC Cancer Center conducts pivotal trials that have led to FDA approval for therapies for metastatic kidney cancer and melanoma (skin cancer).
If you have questions, please call Arline Broberg at 617-975-7403.
Our Biologic Therapy Clinical Trials
Clinical trials are especially important if you have kidney cancer that has spread to other organs (metastasized). Clinical trials offer you the widest array of treatment options, including new drugs and drug combinations that are still under research.
Beth Israel Deaconess Medical Center conducts pivotal trials that have led to FDA approval for therapies for metastatic kidney cancer and melanoma (skin cancer).
We are exploring new treatments and novel agents added to existing treatments. We are also studying how to improve the selection criteria for systemic therapy (affecting the entire body) in order to enhance patient outcomes.
The Cancer Center at BIDMC is an important center of research into the safety and effectiveness of new cancer therapies. Your physician will help you evaluate whether participation in a clinical trial is appropriate for you.
The following clinical trials related to Biologic Therapy are now available through BIDMC. If you have questions about participating in a clinical trial, please call at 617-975-7403.
Updated November 2018.